Reduction of cholesterol and other cardiovascular disease risk factors by alternative therapies

Author： Tappia Paramjit S Xu Yan-Jun Dhalla Naranjan S

ISSN： 1758-4299

Source： Clinical Lipidology, Vol.8, Iss.3, 2013-06, pp. : 345-359

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inverse Association Between Plasma Cholesterol and Gallstone Disease - relation with oral contraceptives and other risk factors

By Duque-L. M.X. Moran S. Salmeron-Castro J. de la Luz Kageyama-E. M. Rodrguez-Leal G. Ramos M.E. Uribe M.

Instituto Mexicano del Seguro Social. Subjefatura de Investigacion. Investigacion, Vol. 30, Iss. 3, 1999-05 ,pp. : 190-197

Elsevier

Access to resources Recommend Favorite

Cardiovascular disease in primary care: concordance and risk reduction

By Knapton Mike

British Journal of General Practice, Vol. 62, Iss. 599, 2012-06 ,pp. : 284-285

Royal College of General Practitioners

Access to resources Recommend Favorite

Diabetes and cardiovascular disease: time for individualized risk reduction

By McFarlane Samy I Sowers James R

Therapy, Vol. 6, Iss. 4, 2009-07 ,pp. : 451-453

Future Medicine

Access to resources Recommend Favorite

Plasma lipoprotein (a), homocysteine, and other cardiovascular disease (CVD) risk factors in Nigerians with CVD

By Ebesunun M.O. Agbedana E.O. Taylor G.O.L. Oladapo O.O.

Applied Physiology, Nutrition, and Metabolism, Vol. 33, Iss. 2, 2008-04 ,pp. : 282-289

NRC Research Press

Access to resources Recommend Favorite

Measurement of Low‐Density Lipoprotein Cholesterol in Assessment and Management of Cardiovascular Disease Risk

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 96, Iss. 1, 2014-07 ,pp. : 20-22

John Wiley & Sons Inc

Access to resources Recommend Favorite